Should off-label drugs be included as comparators in pharmacoeconomic studies?

Pharmacoeconomics. 2014 Nov;32(11):1035-7. doi: 10.1007/s40273-014-0222-2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Costs and Cost Analysis / economics
  • Costs and Cost Analysis / methods*
  • Economics, Pharmaceutical*
  • Humans
  • Off-Label Use / economics*